Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers
NCT00797420 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2018-11-05
Summary
The purpose of this study is to investigate the pharmacokinetics and safety of a fluconazole loading dose in infants and toddlers.
Conditions
- Candidiasis
Interventions
- DRUG
-
Fluconazole Loading Dose
Single Fluconazole loading dose 25 mg/kg
- DRUG
-
Fluconazole Loading Dose & High Dose
Fluconazole loading dose 25 mg/kg, followed by fluconazole 12 mg/kg q24 hours for total of 5 days
Sponsors & Collaborators
-
Pediatric Pharmacology Research Units Network
collaborator NETWORK -
Daniel Benjamin
lead OTHER
Principal Investigators
-
Daniel Benjamin, MD · Duke University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 48 Hours
- Max Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2010-01-31
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Population Pharmacokinetics of Fluconazole in the Treatment of Neonatal Fungal Infectious Disease
NCT05775692 ·Status: UNKNOWN
-
Pharmacokinetic Study of Fluconazole in Premature Infants
NCT01683760 ·Status: COMPLETED ·Phase: PHASE2
-
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight
NCT00734539 ·Status: COMPLETED ·Phase: PHASE3
-
Fluconazole Versus Micafungin in Neonates With Candidiasis
NCT02145832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
NCT01666769 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
NCT00001790 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
NCT00174473 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
NCT02452034 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients
NCT02666716 ·Status: COMPLETED
-
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)
NCT00330395 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
NCT02510053 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
NCT01945281 ·Status: TERMINATED ·Phase: PHASE2
-
Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
NCT03421002 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
NCT01716234 ·Status: TERMINATED ·Phase: PHASE1
-
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
NCT04665037 ·Status: RECRUITING ·Phase: PHASE2
-
Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication
NCT01680458 ·Status: COMPLETED
-
The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
NCT00911235 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
NCT01533558 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
NCT00815516 ·Status: TERMINATED ·Phase: PHASE3
-
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
NCT00607763 ·Status: COMPLETED ·Phase: PHASE1
-
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
NCT04122560 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects
NCT05478772 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates
NCT00818584 ·Status: COMPLETED ·Phase: PHASE1
-
Variability of Fluconazole Concentration in Critically Ill Patients
NCT02491151 ·Status: COMPLETED